CLEImmunoUpdate
@CLEImmunoUpdate
Followers
37
Following
360
Media
4
Statuses
75
Updates from Global Center for Immunotherapy & Precision Immuno-Oncology (CITI @ Cleveland Clinic) | Tweets not of employer
Cleveland, OH
Joined November 2024
RT @DrJFriedberg: Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell Lymphoma | @JCO_ASCO .
ascopubs.org
0
11
0
RT @TylerAlban1: Excited to share our manuscript on quantum machine learning! I’m a believer in team science so here we teamed up with quan….
arxiv.org
Learning on small data is a challenge frequently encountered in many real-world applications. In this work we study how effective quantum ensemble models are when trained on small data problems in...
0
1
0
0
1
0
RT @TylerAlban1: Incredible opportunity to share the stage tonight with @VamsiVelcheti tonight at an amazing venue #ASCO2025 @CLEImmunoUpd….
0
1
0
RT @LauraBukavinaMD: Great day for @HenningPlage to tour @CLEImmunoUpdate labs including Bukavina lab with our amazing team @ram444367 http….
0
2
0
RT @nataliesilvermd: Excited for the upcoming conference. Come join us! @CleClinicHNI @CLEImmunoUpdate.
0
3
0
RT @NIHFunding: The Extramural Nexus has a new home on the NIH Grants and Funding website! 💻 Stay tuned for refreshed content and subscribe….
0
1
0
RT @JustinLathia: Exciting midterm seminar presented by Daniel McGrail - tour deforce on the exciting directions of his laboratory! @CCLRI….
0
2
0
RT @aakonc: Wonderful day of science and tributes in memory of @CharisEngMDPhD aka "Tenacious C" @ClevelandClinic. An incredible legacy of….
0
2
0
RT @GeneCollector: Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy: Cancer Cell .
cell.com
Immune checkpoint inhibitors (ICIs) have improved cancer outcomes but only a minority of patients benefit. In this review, Wang and Chan discuss the utility of currently approved biomarkers of...
0
3
0
RT @OncLive: @shilpaonc, of @CleclinicMD discusses OS outcomes with first-line maintenance avelumab plus BSC in advanced urothelial carcino….
onclive.com
Shilpa Gupta, MD, discusses OS outcomes with first-line maintenance avelumab plus BSC in advanced urothelial carcinoma based on diabetes mellitus.
0
1
0
RT @Salendra_Singh_: Happy holi everyone. I hope you have colorful springs. Thanks to the @GeneCollector admin team for organizing it. @C….
0
3
0
RT @JustinLathia: Great way to end the week at the @CCLRI - Spotlight Seminar featuring three talented physician scientists @AmyAttaway3 @n….
0
1
0
RT @weldeiry: Pleased to share the presentation by Dr. Jacob Scott, @CancerConnector, invited speaker at #LegorretaCancerCenter. He spoke a….
0
2
0
0
0
0
What a great place to support our community! 🙏.
Had a special evening at the @EdwinsCLE .with our ROBIN speaker @mouwlab during his visit to @CleClinicMD @CCLRI . It is always inspiring to enjoy great food and witness the mission the amazing Chef Brandon Edwin Chrostowski is on to reform and uplift the Cleveland community!
0
0
1
RT @shilpaonc: Honored to have @mouwlab @DanaFarber .as our speaker for #U54 ROBIN Luminary lecture @CleClinicMD @CleClinicUro @CCLRI .Fasc….
0
10
0
Our @ClevelandClinic rad onc residents loved having lunch with our U54 ROBIN speaker, @mouwlab, during his visit- thank you for great career advice and insights!
1
1
12
RT @mouwlab: Thanks so much for the invite - I had a great time meeting with the ROBIN and GU teams! .@DanaFarber_GU @BrighamRadOnc.
0
4
0